| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/26/2012 | US20120022236 Recombinant Anti-VLA4 Antibody Molecules |
| 01/26/2012 | US20120022235 Promoter molecules for use in plants |
| 01/26/2012 | US20120022145 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof |
| 01/26/2012 | US20120022141 Compositions and methods for inhibiting expression of a gene from the jc virus |
| 01/26/2012 | US20120022138 Means for inhibiting the expression of ang2 |
| 01/26/2012 | US20120022136 Cellular Genes Regulated by HIV-1 Infection and Methods of Use Thereof |
| 01/26/2012 | US20120022133 Antisense modulation of cholesteryl ester transfer protein expression |
| 01/26/2012 | US20120022132 Compositions and methods for inhibiting expression of mutant egfr gene |
| 01/26/2012 | US20120022130 METHOD OF REGULATING NFATc2 ACTIVITY IN LYMPHOCYTES |
| 01/26/2012 | US20120022125 Pyrrolidine triple reuptake inhibitors |
| 01/26/2012 | US20120022097 Compositions and Methods for Treating Cancer |
| 01/26/2012 | US20120022083 Small molecule modulators of cell adhesion |
| 01/26/2012 | US20120022076 Derivatives of n-(arylamino)sulfonamides as inhibitors of mek |
| 01/26/2012 | US20120022065 C-Met Modulators and Method of Use |
| 01/26/2012 | US20120022026 Method of treating cancer |
| 01/26/2012 | US20120022014 Tetrahydropyran nucleic acid analogs |
| 01/26/2012 | US20120022013 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 01/26/2012 | US20120022005 Synthetic Dragline Spider Silk-Like Proteins |
| 01/26/2012 | US20120022000 Use of a peptide in the treatment or prevention of metastasis |
| 01/26/2012 | US20120021999 Pro-apoptotic peptides |
| 01/26/2012 | US20120021985 Albumin fusion proteins |
| 01/26/2012 | US20120021984 Glycoprotein Hormone Analogs |
| 01/26/2012 | US20120021983 Compositions and methods for diagnosis and prognosis of cancer and progression, and for screening anti-cancer agents |
| 01/26/2012 | US20120021981 Compositions to prevent and treat type-1 diabetes |
| 01/26/2012 | US20120021975 Antibiotic peptides |
| 01/26/2012 | US20120021522 Method for the Evolutionary Design of Biochemical Reaction Networks |
| 01/26/2012 | US20120021519 Efficient induction of pluripotent stem cells using small molecule compounds |
| 01/26/2012 | US20120021518 Growth factor homolog zvegf4 |
| 01/26/2012 | US20120021517 Bacterial Mediated Delivery of Nuclear Protein Into Pluripotent and Differentiated Cells |
| 01/26/2012 | US20120021516 NOVEL STRUCTURALLY DESIGNED shRNAs |
| 01/26/2012 | US20120021515 Oligomeric compounds and methods |
| 01/26/2012 | US20120021514 Heterogeneous polymeric micelles for intracellular delivery |
| 01/26/2012 | US20120021513 Small molecules supporting pluripotent cell growth and methods thereof |
| 01/26/2012 | US20120021512 Interleukin-1 Alpha Antibodies and Methods of Use |
| 01/26/2012 | US20120021511 Preprimitive streak and mesendoderm cells |
| 01/26/2012 | US20120021510 Method for improved single cell cloning |
| 01/26/2012 | US20120021509 Isolating method for umbilical cord blood-derived pluripotent stem cells expressing znf281 |
| 01/26/2012 | US20120021508 Method and Device for Identification of Nucleated Red Blood Cells from a Maternal Blood Sample |
| 01/26/2012 | US20120021507 Bioreactor and uses thereof |
| 01/26/2012 | US20120021491 Identification of antigen or ligand-specific binding proteins |
| 01/26/2012 | US20120021490 Glucanases, nucleic acids encoding them and methods for making and using them |
| 01/26/2012 | US20120021482 Methods for isolating very small embryonic-like (vsel) stem cells |
| 01/26/2012 | US20120021470 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 01/26/2012 | US20120021464 Thermostable reverse transcriptases and uses thereof |
| 01/26/2012 | US20120021459 Feed media |
| 01/26/2012 | US20120021440 Methods for testing ligand binding to g protein-coupled receptors |
| 01/26/2012 | US20120021434 Method for treating b cell regulated autoimmune disorders |
| 01/26/2012 | US20120021430 Functional lipid constructs |
| 01/26/2012 | US20120021417 DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKER Nato3 |
| 01/26/2012 | US20120021411 Automated high-throughput seed sampler and methods of sampling, testing and bulking seeds |
| 01/26/2012 | US20120021405 Single Chain Antibody for the Detection of Noroviruses |
| 01/26/2012 | US20120021080 Production and Extraction of Procyanidins from Plant Cell Cultures |
| 01/26/2012 | US20120021063 Crosslinked material comprising elastin and collagen, and use thereof |
| 01/26/2012 | US20120021042 Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances |
| 01/26/2012 | US20120021039 Expression of neuropeptides in mammalian cells |
| 01/26/2012 | US20120021035 Nanoparticles containing plymeric nucleic acid homologs, pharmaceutical composition and articles of manufacture containing same and methods of use thereof |
| 01/26/2012 | US20120021019 Cardiac stem cell populations for repair of cardiac tissue |
| 01/26/2012 | US20120020998 Plasmacytoid dendritic cell line used in active or adoptive cell therapy |
| 01/26/2012 | US20120020997 Multi plasmid system for the production of influenza virus |
| 01/26/2012 | US20120020992 Production of Biologically Active Proteins |
| 01/26/2012 | US20120020990 Isolated mammalian monocyte cell genes; related reagents |
| 01/26/2012 | US20120020988 Antibodies specifically binding to human TSLPR and methods of use |
| 01/26/2012 | US20120020987 MHC-Less cells |
| 01/26/2012 | US20120020985 Antibodies against il-17br |
| 01/26/2012 | US20120020980 High affinity human antibodies to human cytomegalovirus (cmv) gb protein |
| 01/26/2012 | US20120020973 Chimeric ospa genes, proteins, and methods of use thereof |
| 01/26/2012 | US20120020972 Antibodies relating to pivka-ii and uses thereof |
| 01/26/2012 | US20120020971 Antibodies useful in passive influenza immunization |
| 01/26/2012 | US20120020969 Compositions And Methods For Inhibiting Viral Adhesion |
| 01/26/2012 | US20120020967 VEGF antibodies comprising modular recognition domains |
| 01/26/2012 | US20120020966 Multispecific antibody targeting and multivalency through modular recognition domains |
| 01/26/2012 | US20120020965 Molecules that bind CD180, compositions and methods of use |
| 01/26/2012 | US20120020961 Methods and compositions for liver cancer therapy |
| 01/26/2012 | US20120020957 Dengue virus neutralizing antibodies and use thereof |
| 01/26/2012 | US20120020952 Methods for producing mixtures of antibodies |
| 01/26/2012 | US20120020949 MHC-LESS cells |
| 01/26/2012 | US20120020940 Antimicrobial peptides |
| 01/26/2012 | US20120020937 Autologous and allogenic adipose-derived stromal stem cell composition for treating fistulas |
| 01/26/2012 | US20120020936 Treatment of neurodegenerative disease using placental stem cells |
| 01/26/2012 | US20120020935 Cardiac stem cells and methods for isolation of same |
| 01/26/2012 | US20120020934 Materials and methods for cryopreserved bone constructs |
| 01/26/2012 | US20120020930 Methods for the preparation of adipose derived stem cells and utilizing said cells in the treatment of diseases |
| 01/26/2012 | US20120020929 Methods and compositions relating to neuronal cell and tissue differentiation |
| 01/26/2012 | US20120020925 Therapeutic Use of Specialized Endothelial Progenitor Cells |
| 01/26/2012 | US20120020911 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 01/26/2012 | US20120020889 Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin |
| 01/26/2012 | US20120020885 MHC-Less cells |
| 01/26/2012 | US20120020876 Hedgehog pathway inhibitors |
| 01/26/2012 | CA2842294A1 Methods for isolating and using a subset of cd8 t-cells that are resistant to cyclosporin |
| 01/26/2012 | CA2806147A1 Systems and methods for detection of cellular stress |
| 01/26/2012 | CA2806127A1 Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| 01/26/2012 | CA2805799A1 Plant-based production of heterologous proteins |
| 01/26/2012 | CA2805442A1 Methods and compositions for modification of an hla locus |
| 01/25/2012 | EP2410337A1 Method for measuring -glucan, and -glucan-binding protein for use in the method |
| 01/25/2012 | EP2410331A1 Aminoacyl-tRNA synthetase for aminoacylation tRNA with unnatural amino acids |
| 01/25/2012 | EP2410051A1 NOVEL ACETYL-CoA CARBOXYLASE |
| 01/25/2012 | EP2410049A1 RNA detection enzymes |
| 01/25/2012 | EP2410046A2 Isolating method for umbilical cord blood-derived pluripotent stem cells expressing znf281 |
| 01/25/2012 | EP2410045A1 A method for testing an immune response |
| 01/25/2012 | EP2410044A2 Stem cells culture systems |